A major new study shows that giving heart attack patients a cholesterol-lowering combo treatment early on – not months later ...

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all.

One of AI’s most immediate impacts is in screening and identifying patients who may have asymptomatic or paroxysmal AF, those ...

Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 ...